Standard Millox Pharmaceuticals Oy

OYDissolved

Y-tunnus 3244336-7Meri-Penniläntie 66, 20960 TurkuDiagnostic imaging services and medical laboratory activities· NACE 8691Est. 2021 · 4 years old— employees

Overview Financials People & ownership Related companies

Standard Millox Pharmaceuticals Oy er finsk OY med hjemsted i Turku, som opererer i Diagnostic imaging services and medical laboratory activities-sektoren. Stiftet i 2021 rapporterede en omsætning på EUR 0 i seneste årsrapport.

Omsætning 2024

EUR 0

EBITDA-margin

—

Nettoresultat 2024

EUR 0

Nøgletal

Se alle nøgletal →

85.7%

This company

20222024

0.0×

This company

20222024

0.0%

This company

20222024

EBITDA — year on year

EUR millions

Key figures

Annual report 2024

Revenue	EUR 0	—
EBITDA	EUR 0	—
Net profit	EUR 0	—
Total assets	EUR 672K	+17%
Equity	EUR 576K	0%
Employees	—	—

Contact

Address

Meri-Penniläntie 66, 20960 Turku

Phone

+3580405445119

tommi.brunila@gmail.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Ofte stillede spørgsmål

Hvad er Y-tunnus-nummeret på Standard Millox Pharmaceuticals Oy?

Standard Millox Pharmaceuticals Oy er registreret hos PRH / YTJ under Y-tunnus 3244336-7.

Hvem er administrerende direktør i Standard Millox Pharmaceuticals Oy?

Jukka Petri Olavi Toivanen er administrerende direktør i Standard Millox Pharmaceuticals Oy, i rollen siden 2025.

Hvem er bestyrelsesformand i Standard Millox Pharmaceuticals Oy?

Juhani Tuomas Soini er bestyrelsesformand i Standard Millox Pharmaceuticals Oy, i rollen siden 2025.

Hvor har Standard Millox Pharmaceuticals Oy hovedsæde?

Standard Millox Pharmaceuticals Oys registrerede adresse er Meri-Penniläntie 66.

Standard Millox Pharmaceuticals Oy

Nøgletal

EBITDA — year on year

Key figures

Company information

Contact

Ofte stillede spørgsmål

More on Standard Millox Pharmaceuticals Oy

Nøgletal

EBITDA — year on year

Key figures

Company information

Contact

Ofte stillede spørgsmål

More on Standard Millox Pharmaceuticals Oy